Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma

Autor: Allen, Jessica L., Hames, River A., Mastroianni, Natalie M., Greenstein, Andrew E., Weed, Scott A.
Zdroj: In Oral Oncology September 2022 132
Databáze: ScienceDirect